Financial Instruments - Schedule of Available-for-Sale Marketable Securities (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	$ 218,392	$ 13,786
Unrealized Gain	78	0
Unrealized Losses	(2,544)	(4)
Fair Value	215,926	13,782
Corporate Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	184,321	7,716
Unrealized Gain	75	0
Unrealized Losses	(2,344)	(1)
Fair Value	182,052	7,715
U.S Treasury and Agency Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	34,071	6,070
Unrealized Gain	3	0
Unrealized Losses	(200)	(3)
Fair Value	$ 33,874	$ 6,067